Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-Nī-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate

EU orphan designation number: EU/3/10/747   
Active ingredient: N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-Nī-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate
Indication: Treatment of renal cell carcinoma
Sponsor: Astellas Pharma Europe B.V.
Sylviusweg 62, NL-2333 BE Leiden, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2010 Centralised Orphan - Designation EMEA/OD/148/09 (2010)3840 of 09/06/2010
07/03/2012 Centralised Orphan - Transfer of orphan designation EMEA/OD/148/09/T/01 (2012)1538 of 05/03/2012
04/02/2013 Other procedure